Fusion Pharmaceuticals (FUSN) Short Interest Ratio & Short Volume

+0.05 (+0.23%)
(As of 05/17/2024 ET)

Fusion Pharmaceuticals Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
$84.65 million
Short Interest Ratio / Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
Percentage of Shares Shorted
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Fusion Pharmaceuticals ?

Sign up to receive the latest short interest report for Fusion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FUSN Short Interest Over Time

FUSN Days to Cover Over Time

FUSN Percentage of Float Shorted Over Time

Fusion Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20243,950,000 shares $84.65 million -18.7%N/A2 $21.43
4/15/20244,860,000 shares $103.42 million -6.5%N/A2.3 $21.28
3/31/20245,200,000 shares $110.86 million -34.3%N/A2.4 $21.32
3/15/20247,920,000 shares $79.12 million -8.3%N/A3.6 $9.99
2/29/20248,640,000 shares $103.33 million +27.1%N/A6.9 $11.96
2/15/20246,800,000 shares $79.70 million +62.3%N/A6 $11.72
1/31/20244,190,000 shares $48.69 million +30.9%N/A4.4 $11.62
1/15/20243,200,000 shares $28.83 million +107.8%N/A4.5 $9.01
12/31/20231,540,000 shares $14.80 million +1,618.8%N/A2.3 $9.61
12/15/202389,600 shares $470,400.00 -17.0%N/A0.2 $5.25
11/30/2023107,900 shares $597,766.00 +17.0%N/A0.5 $5.54
11/15/202392,200 shares $385,396.00 -35.9%N/A0.5 $4.18
10/31/2023143,900 shares $663,379.00 -0.4%N/A1 $4.61
10/15/2023144,400 shares $596,372.00 +42.1%N/A1 $4.13
9/30/2023101,600 shares $264,160.00 -21.1%N/A1.2 $2.60
9/15/2023128,800 shares $331,016.00 +42.2%N/A2.8 $2.57
8/31/202390,600 shares $269,988.00 -7.8%N/A1.8 $2.98
8/15/202398,300 shares $298,832.00 -2.9%N/A1.7 $3.04
7/31/2023101,200 shares $328,900.00 -17.3%N/A2 $3.25
7/15/2023122,400 shares $501,840.00 +1.9%N/A2.8 $4.10
6/30/2023120,100 shares $560,867.00 +14.9%N/A2.1 $4.67
6/15/2023104,500 shares $484,880.00 -56.8%N/A1.5 $4.64
5/31/2023241,900 shares $1.23 million -11.4%N/A3.4 $5.10
5/15/2023272,900 shares $1.25 million +1.7%N/A3.5 $4.58
4/30/2023268,300 shares $1.03 million -18.0%N/A0.8 $3.85
4/15/2023327,200 shares $1.33 million -0.1%N/A0.9 $4.06
3/31/2023327,500 shares $1.23 million +45.5%N/A0.9 $3.77
3/15/2023225,100 shares $945,420.00 No ChangeN/A0.6 $4.20
2/28/2023225,100 shares $994,942.00 -66.7%0.7%0.6 $4.42
2/15/2023675,600 shares $3.12 million +19.2%2.2%1.9 $4.62
1/31/2023566,800 shares $1.72 million -1.7%1.9%7.4 $3.03
1/15/2023576,800 shares $2.25 million +1.7%1.9%10.5 $3.90
12/30/2022567,300 shares $1.79 million -0.5%1.9%10.7 $3.15
12/15/2022570,000 shares $1.57 million -1.2%1.9%10.5 $2.76
11/30/2022576,700 shares $1.31 million +57.2%1.9%6.2 $2.27
11/15/2022366,800 shares $781,284.00 +47.3%1.2%3.9 $2.13
10/31/2022249,100 shares $610,295.00 +49.3%0.9%2.4 $2.45
10/15/2022166,900 shares $375,525.00 +133.1%0.6%1.5 $2.25
9/30/202271,600 shares $215,516.00 +92.0%0.3%0.6 $3.01
9/15/202237,300 shares $117,495.00 +50.4%0.1%0.3 $3.15
A letter is coming from the "Bureau of the Fiscal Service". (Ad)

Is your bank next? A powerful new trend is spreading like wildfire inside the US financial system. At least 41 banks are already involved. But the Federal Reserve predicts that number will grow fast.

See if your bank is involved right here.

FUSN Short Interest - Frequently Asked Questions

What is Fusion Pharmaceuticals' current short interest?

Short interest is the volume of Fusion Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,950,000 shares of FUSN short. Learn More on Fusion Pharmaceuticals' current short interest.

What is a good short interest ratio for Fusion Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FUSN shares currently have a short interest ratio of 2.0. Learn More on Fusion Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Fusion Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fusion Pharmaceuticals: Fifth Lane Capital LP, and Equitec Proprietary Markets LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Fusion Pharmaceuticals' short interest increasing or decreasing?

Fusion Pharmaceuticals saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 3,950,000 shares, a decline of 18.7% from the previous total of 4,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Fusion Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Fusion Pharmaceuticals: Inhibrx, Inc. (4.18%), Ginkgo Bioworks Holdings, Inc. (20.84%), Novavax, Inc. (32.00%), Sana Biotechnology, Inc. (20.85%), Beam Therapeutics Inc. (17.03%), ADMA Biologics, Inc. (3.82%), Neumora Therapeutics, Inc. (12.27%), Kymera Therapeutics, Inc. (16.15%), Tarsus Pharmaceuticals, Inc. (20.28%), Apogee Therapeutics, Inc. (14.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Fusion Pharmaceuticals stock?

Short selling FUSN is an investing strategy that aims to generate trading profit from Fusion Pharmaceuticals as its price is falling. FUSN shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fusion Pharmaceuticals?

A short squeeze for Fusion Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FUSN, which in turn drives the price of the stock up even further.

How often is Fusion Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FUSN, twice per month. The most recent reporting period available is April, 30 2024.

More Short Interest Resources from MarketBeat

This page (NASDAQ:FUSN) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners